Last reviewed · How we verify

NCT04185168

Isoflavones and Peritoneal Dialysis

Completed NA Last updated 6 February 2020
What this trial tests

NA trial testing soy isoflavone in Peritoneal Dialysis in 38 participants. Completed in 18 January 2020.

Timeline
16 November 2019
Primary endpoint
18 January 2020
18 January 2020

Quick facts

Lead sponsorNational Nutrition and Food Technology Institute
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment38
Start date16 November 2019
Primary completion18 January 2020
Estimated completion18 January 2020
Sites1 location across Iran

Drugs / interventions tested

Conditions studied

Sponsor

National Nutrition and Food Technology Institute

Who can join

Adults 18 to 75, any sex, with Peritoneal Dialysis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this double-blind randomized clinical trial is to determine the effects of isoflavones on serum concentrations of fructoseamine and advanced glycated end products in peritoneal dialysis patients. Forty-four patients from shafa clinic will randomly assign to either isoflavone or placebo group. The patients in isoflavone group will receive 100 mg soy isoflavone (as 2 capsules) daily for 8 weeks, while the placebo group will receive identical placebo. At the baseline and the end of the study,7 ml blood will be collected from each patient after a 12-14-hours fasting and serum concentrations of fructoseamine, carboxymethyl lysine, pentosidine, glucose will be measured. Furthermore, blood pressure measurements will be performed twice with a ten-minute interval between testing

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Peritoneal Dialysis

Currently open trials in the same condition.

Other National Nutrition and Food Technology Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04185168.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing